Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed a repurchase of 400,000 H-shares on 09 July 2026.

The shares were bought on the Hong Kong Stock Exchange at prices ranging from HKD 3.20 to HKD 3.25, for a total consideration of HKD 1.29 million. All repurchased shares were retained as treasury stock.

After the transaction: • Outstanding issued shares fell 0.009 % to 4,461.43 million. • Treasury shares increased to 60.90 million, keeping the total issued share count unchanged at 4,522.33 million.

Repurchase mandate status: • Shareholders granted authority on 29 May 2026 for up to 446.46 million shares. • Cumulative buybacks under the mandate now stand at 3.57 million shares, equivalent to 0.80 % of the share base on the mandate date. • In accordance with HKEX rules, Weigao Group is restricted from issuing new shares or selling treasury shares until 08 August 2026.

The company confirmed that the repurchase complied with all applicable listing rules and regulatory requirements.